Search
for

    GlossaryTofacitinib

    inhibits Janus kinase enzymes to treat autoimmune conditions

    Tofacitinib, also known by the brand name Xeljanz, is a medication that inhibits Janus kinase (JAK) enzymes, which play a role in the inflammatory process. It is used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, and has also shown promise in treating alopecia areata, a condition that causes hair loss.

    Related Terms

    Learn

    2 / 2 results

      learn Tofacitinib

      a JAK inhibitor for alopecia areata and other autoimmune conditions

    Research

    5 / 686 results

    Community Join

    5 / 6 results